Suppr超能文献

黄芪桂枝五物汤治疗中风后麻木和虚弱的作用机制:计算分子对接研究。

Mechanisms of Action of a Herbal Formula Huangqi Guizhi Wuwu Tang for the Management of Post-Stroke Related Numbness and Weakness: A Computational Molecular Docking Study.

机构信息

School of Health and Biomedical Sciences, 5376RMIT University, Bundoora, Victoria 3083, Australia.

Science, 5376RMIT University, Melbourne, Victoria 3000, Australia.

出版信息

J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221082989. doi: 10.1177/2515690X221082989.

Abstract

Stroke-related numbness and weakness (SRNW) are resultant symptoms of post-stroke sufferers. Existing research has supported the use of Huangqi Guizhi Wuwu Tang (HGWT) particularly for SRNW; however, their mechanisms of action have not been fully elucidated. Therefore, this study aimed to investigate the mechanisms of action of HGWT components targeting SRNW-related proteins through a computational molecular docking approach. Target proteins associated with SRNW were identified through DrugBank database and Open Targets database. Chemical compounds from each herb of HGWT were identified from the Traditional Chinese Medicine Systems Pharmacology and Analysis Platform (TCMSP). Autodock Vina was utilized and the cut-off criterion applied for protein-ligand complexes was a binding affinity score of ≤ -9.5 kcal/mol; selected protein-ligand complexes were identified using 3D and 2D structural analyses. The protein targets PDE5A and ESR1 have highlighted interactions with compounds (BS040, DZ006, DZ058, DZ118, and HQ066) which are the key molecules in the management of SRNW. PDE5A have bioactivity with the amino acid residues (Val230, Asn252, Gln133 and Thr166) throughout PDE5A-cGMP-PKG pathways which involved reduction in myofilament responsiveness. ESR1 were predicted to be critical active with site residue (Leu346, Glu419 and Leu387) and its proteoglycans pathway involving CD44v3/CD44 that activates rho-associated protein kinase 1 (ROCK1) and ankyrin increasing vascular smooth muscle. In conclusion, HGWT may provide therapeutic benefits through strong interactions between herbal compounds and target proteins of PDE5A and ESR1. Further experimental studies are needed to unequivocally support this result which can be valuable to increase the quality of life of post-stroke patients. Herbal medicine, Complementary and alternative medicine, Natural product, Post-stroke, Computational analysis.

摘要

中风相关的麻木和无力(SRNW)是中风患者的继发症状。现有研究支持使用黄芪桂枝五物汤(HGWT)治疗 SRNW,但它们的作用机制尚未完全阐明。因此,本研究旨在通过计算分子对接方法研究 HGWT 成分针对与 SRNW 相关的蛋白质的作用机制。通过 DrugBank 数据库和 Open Targets 数据库确定与 SRNW 相关的靶蛋白。从中药系统药理学和分析平台(TCMSP)中确定了 HGWT 每种草药的化学化合物。使用 Autodock Vina 并应用蛋白-配体复合物的截止标准为结合亲和力评分≤-9.5 kcal/mol;使用 3D 和 2D 结构分析鉴定选定的蛋白-配体复合物。PDE5A 和 ESR1 蛋白靶标与化合物(BS040、DZ006、DZ058、DZ118 和 HQ066)之间存在相互作用,这些化合物是管理 SRNW 的关键分子。PDE5A 在 PDE5A-cGMP-PKG 途径中与氨基酸残基(Val230、Asn252、Gln133 和 Thr166)具有生物活性,该途径涉及肌丝反应性降低。ESR1 被预测为关键活性,其位点残基(Leu346、Glu419 和 Leu387)及其蛋白聚糖途径涉及 CD44v3/CD44,激活 rho 相关蛋白激酶 1(ROCK1)和锚蛋白增加血管平滑肌。总之,HGWT 可能通过草药化合物与 PDE5A 和 ESR1 靶蛋白之间的强烈相互作用提供治疗益处。需要进一步的实验研究来明确支持这一结果,这对提高中风后患者的生活质量具有重要意义。草药、补充和替代医学、天然产物、中风后、计算分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b863/8984862/f5d875787303/10.1177_2515690X221082989-fig1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验